While Oxaliplatin kills colon cancer cells through the induction of DNA damage, it seems to induce the overexpression of tumor-associated antigens and the downregulation of programmed death-ligand 1 (PD-L1) expression [27,28,29,30]. Here, CD274 is linked to neoplasm.